 |
MorphoSys AG
MOR
|
-0.591 |
- |
2.43 % |
$ 254 M |
Germany |
 |
ARCA biopharma
ABIO
|
1.84 |
- |
1052.0 % |
$ 415 M |
USA |
 |
Amarin Corporation plc
AMRN
|
123 |
$ 14.67 |
- |
$ 6.09 B |
Irlanda |
 |
Aeterna Zentaris
AEZS
|
4.4 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
-1.85 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 |
- |
- |
$ 1.01 B |
USA |
 |
AIkido Pharma
AIKI
|
-45.5 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Akouos
AKUS
|
-1.13 |
- |
0.23 % |
$ 488 M |
USA |
 |
Akero Therapeutics
AKRO
|
-4.64 |
- |
- |
$ 3.67 B |
USA |
 |
I-Mab
IMAB
|
595 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
4.22 K |
- |
2.54 % |
$ 160 B |
France |
 |
Albireo Pharma
ALBO
|
-3.38 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Biophytis SA
BPTS
|
-17.6 |
- |
-13.47 % |
$ 169 M |
France |
 |
Cabaletta Bio
CABA
|
0.778 |
$ 2.82 |
- |
$ 283 M |
USA |
 |
Aileron Therapeutics
ALRN
|
-0.0369 |
- |
10.36 % |
$ 9.8 M |
USA |
 |
Aptinyx
APTX
|
-1.56 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
0.796 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
-9.01 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
190 |
$ 0.66 |
-0.45 % |
$ 7.56 M |
Israel |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 |
- |
- |
$ 26.5 M |
USA |
 |
Avenue Therapeutics
ATXI
|
0.871 |
- |
-52.27 % |
$ 4.45 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 |
- |
- |
$ 7.46 M |
Israel |
 |
CEL-SCI Corporation
CVM
|
-5.22 |
$ 3.47 |
- |
$ 221 M |
USA |
 |
Atreca
BCEL
|
-2.76 |
- |
-11.76 % |
$ 5.79 M |
USA |
 |
Acorda Therapeutics
ACOR
|
0.777 |
- |
-24.86 % |
$ 820 K |
USA |
 |
bluebird bio
BLUE
|
-0.805 |
- |
- |
$ 546 M |
USA |
 |
Denali Therapeutics
DNLI
|
-14.1 |
$ 19.74 |
- |
$ 3.25 B |
USA |
 |
Acasti Pharma
ACST
|
1.8 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Институт стволовых клеток человека
ISKJ
|
14 |
- |
- |
- |
Russia |
 |
Avid Bioservices
CDMO
|
109 |
- |
- |
$ 789 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
-1.32 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
-3.39 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
-82.4 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 |
$ 1.29 |
- |
$ 329 M |
Britain |
 |
Esperion Therapeutics
ESPR
|
-2.15 |
$ 2.85 |
- |
$ 592 M |
USA |
 |
EyePoint Pharmaceuticals
EYPT
|
-4.47 |
$ 13.06 |
- |
$ 957 K |
USA |
 |
BeiGene, Ltd.
BGNE
|
-208 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
BioDelivery Sciences International
BDSI
|
8 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Cara Therapeutics
CARA
|
-6.7 |
- |
-3.03 % |
$ 260 M |
USA |
 |
ChemoCentryx
CCXI
|
-0.721 |
- |
- |
$ 3.74 B |
USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
-1 |
$ 1.09 |
- |
$ 22.4 M |
Israel |
 |
Enochian Biosciences
ENOB
|
-7.22 |
- |
- |
$ 40.5 M |
USA |
 |
CureVac N.V.
CVAC
|
-7.74 |
- |
- |
$ 867 M |
Germany |
 |
Equillium
EQ
|
-1.46 |
$ 2.06 |
- |
$ 118 M |
USA |
 |
Eton Pharmaceuticals
ETON
|
-53 |
$ 23.45 |
- |
$ 631 M |
USA |
 |
Bellerophon Therapeutics
BLPH
|
0.0235 |
- |
-74.18 % |
$ 955 K |
USA |
 |
CRISPR Therapeutics AG
CRSP
|
13.1 |
$ 47.55 |
- |
$ 4.28 B |
Schweiz |
 |
Arbutus Biopharma Corporation
ABUS
|
-3.41 |
$ 4.45 |
- |
$ 853 M |
Canada |